Ibrutinib Is effective in relapsed CLL

J. C. Byrd; R. R. Furman; S. E. Coutre; I. W. Flinn; J. A. Burger; K. A. Blum

doi:10.1158/2159-8290.CD-RW2013-142

Ibrutinib Is effective in relapsed CLL

J. C. Byrd, R. R. Furman, S. E. Coutre, I. W. Flinn, J. A. Burger, K. A. Blum

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Journal	Cancer discovery
Volume	3
Issue number	8
DOIs	https://doi.org/10.1158/2159-8290.CD-RW2013-142
State	Published - Aug 2013

ASJC Scopus subject areas

Oncology

Access to Document

10.1158/2159-8290.CD-RW2013-142

Cite this

@article{d59bc8b374cb4154a6b72deca56d8f0a,

title = "Ibrutinib Is effective in relapsed CLL",

author = "Byrd, {J. C.} and Furman, {R. R.} and Coutre, {S. E.} and Flinn, {I. W.} and Burger, {J. A.} and Blum, {K. A.}",

year = "2013",

month = aug,

doi = "10.1158/2159-8290.CD-RW2013-142",

language = "English (US)",

volume = "3",

journal = "Cancer discovery",

issn = "2159-8274",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}

TY - JOUR

T1 - Ibrutinib Is effective in relapsed CLL

AU - Byrd, J. C.

AU - Furman, R. R.

AU - Coutre, S. E.

AU - Flinn, I. W.

AU - Burger, J. A.

AU - Blum, K. A.

PY - 2013/8

Y1 - 2013/8

UR - http://www.scopus.com/inward/record.url?scp=84881503524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881503524&partnerID=8YFLogxK

U2 - 10.1158/2159-8290.CD-RW2013-142

DO - 10.1158/2159-8290.CD-RW2013-142

M3 - Comment/debate

AN - SCOPUS:84881503524

SN - 2159-8274

VL - 3

JO - Cancer discovery

JF - Cancer discovery

IS - 8

ER -

Ibrutinib Is effective in relapsed CLL

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this